HMGB1 and HMGB2 interact with other proteins encoded by genes whose expression is amplified by increasing copy number (genes with high copy number variations, CNVs) in tumors from patients diagnosed with these aggressive PCa cancers or in metastatic tumors; these genes are not amplified in primary adenocarcinomas [18]. This evidence concerns the gene HMGB2 and cancer.